melarsoprol has been researched along with Brain Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allan, M; Blum, J; Burri, C; Edielu, A; Haary, EP; Kakembo, A; Kibona, S; Kuepfer, I; Schmid, C | 1 |
| Bisser, S; Būscher, P; Lejon, V; Miaka Mia Bilenge, C; N'Siesi, FX; Preux, PM; Van Nieuwenhove, S | 1 |
| Checkley, AM; Gibson, WC; Jäger, HR; Mabey, DC; Pepin, J; Taylor, MN | 1 |
| Hochmann, A; Lambert, PH; Poltera, AA | 1 |
| Ancelle, T; Barret, B; Flachet, L; Moren, A | 1 |
| Chauvière, G; Jennings, FW; Murray, M; Viode, C | 1 |
| Bouteille, B; Dumas, M | 1 |
| Blum, J; Brun, R; Burri, C; Merolle, A; Nkunku, S; Smith, T | 1 |
| Golden, MH | 1 |
| Kernbaum, S; Pialoux, G; Vachon, F | 1 |
| Arroz, JO | 1 |
| Champalimaud, JL; Medina, EA; Ventura, FA | 1 |
| Agbowu, J; Ajayi, N; Weir, AB | 1 |
| Adams, H; Dago, A; Haller, L; Merouze, F | 1 |
3 trial(s) available for melarsoprol and Brain Diseases
| Article | Year |
|---|---|
Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness.
Topics: Adolescent; Adult; Aged; Brain Diseases; Child; Drug Administration Schedule; Endemic Diseases; Female; Humans; Male; Melarsoprol; Middle Aged; Suramin; Tanzania; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosomiasis, African; Uganda | 2012 |
Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
Topics: Administration, Oral; Adult; Animals; Brain Diseases; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Melarsoprol; Nifurtimox; Recurrence; Treatment Outcome; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2007 |
Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.
Topics: Adult; Angola; Animals; Brain Diseases; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Length of Stay; Male; Melarsoprol; Middle Aged; Severity of Illness Index; Time Factors; Treatment Outcome; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2000 |
11 other study(ies) available for melarsoprol and Brain Diseases
| Article | Year |
|---|---|
Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.
Topics: Adult; Animals; Brain Diseases; Humans; Magnetic Resonance Imaging; Male; Melarsoprol; Polymerase Chain Reaction; Recurrence; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2007 |
Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
Topics: Animals; Antigen-Antibody Complex; Arsenicals; Brain; Brain Diseases; Chloroquine; Fluorescent Antibody Technique; Injections, Intraperitoneal; Injections, Intravenous; Melarsoprol; Mice; Nitroimidazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1981 |
[2 epidemics of arsenical encephalopathy in the treatment of trypanosomiasis, Uganda, 1992-1993].
Topics: Adolescent; Adult; Brain Diseases; Child; Disease Outbreaks; Drug Administration Schedule; Drug Interactions; Female; Health Status; Humans; Incidence; Male; Melarsoprol; Middle Aged; Retrospective Studies; Risk Factors; Seasons; Strongyloidiasis; Thiabendazole; Trypanocidal Agents; Trypanosomiasis, African; Uganda | 1994 |
Topical chemotherapy for experimental African trypanosomiasis with cerebral involvement: the use of melarsoprol combined with the 5-nitroimidazole, megazol.
Topics: Administration, Topical; Animals; Brain Diseases; Dimethyl Sulfoxide; Drug Therapy, Combination; Female; Gels; Melarsoprol; Mice; Mice, Inbred Strains; Propylene Glycol; Propylene Glycols; Thiadiazoles; Trypanocidal Agents; Trypanosomiasis, African | 1996 |
[Current status of trypanosomiasis].
Topics: Africa; Animals; Autoantibodies; Blood-Brain Barrier; Brain Diseases; Follow-Up Studies; Forecasting; Humans; Incidence; Melarsoprol; Nitroimidazoles; Pentamidine; Population Surveillance; Protozoan Vaccines; Recurrence; Social Problems; Socioeconomic Factors; Survival Rate; Trypanocidal Agents; Trypanosoma; Trypanosomiasis, African | 1997 |
Arsenic, selenium, and African trypanosomiasis.
Topics: Brain Diseases; Humans; Melarsoprol; Selenium; Trypanosomiasis, African | 1992 |
[Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
Topics: Adult; Animals; Arsenicals; Brain Diseases; Humans; Male; Melarsoprol; Trypanosoma brucei gambiense; Trypanosomiasis, African | 1988 |
Melarsoprol and reactive encephalopathy in Trypanosoma brucei rhodesiense.
Topics: Arsenicals; Brain Diseases; Humans; Melarsoprol; Trypanosoma brucei brucei; Trypanosomiasis, African | 1987 |
Computer-assisted tomographic findings in a patient with African trypanosomiasis.
Topics: Brain Diseases; Child, Preschool; Diminazene; Humans; Male; Melarsoprol; Meningoencephalitis; Recurrence; Tomography, X-Ray Computed; Trypanosomiasis, African | 1986 |
Hyperendemic West African trypanosomiasis in a rural hospital setting.
Topics: Brain Diseases; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Hospitals, Rural; Humans; Melarsoprol; Nigeria; Suramin; Trypanosomiasis, African | 1985 |
Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy.
Topics: Animals; Arsenicals; Brain Diseases; Humans; Melarsoprol; Seizures; Trypanosoma brucei gambiense; Trypanosomiasis, African | 1986 |